人血液中次黄嘌呤鸟嘌呤磷酸核糖基转移酶突变T细胞的分子特征:免疫相关细胞替代选择的概念

IF 6.4 2区 医学 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Noah A. Kaitz , Cindy L. Zuleger , Peng Yu , Michael A. Newton , Richard J. Albertini , Mark R. Albertini
{"title":"人血液中次黄嘌呤鸟嘌呤磷酸核糖基转移酶突变T细胞的分子特征:免疫相关细胞替代选择的概念","authors":"Noah A. Kaitz ,&nbsp;Cindy L. Zuleger ,&nbsp;Peng Yu ,&nbsp;Michael A. Newton ,&nbsp;Richard J. Albertini ,&nbsp;Mark R. Albertini","doi":"10.1016/j.mrrev.2022.108414","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>Somatic cell </span>gene mutations<span><span><span> arise in vivo due to replication errors during DNA synthesis<span> occurring spontaneously during normal DNA synthesis or as a result of replication on a DNA template damaged by endogenous or exogenous </span></span>mutagens<span>. In principle, changes in the frequencies of mutant cells in vivo in humans reflect changes in exposures to exogenous or endogenous DNA damaging insults, other factors being equal. It is becoming increasingly evident however, that </span></span>somatic mutations<span><span> in humans have a far greater range of interpretations. For example, mutations in lymphocytes provide invaluable probes for in vivo cellular and molecular processes, providing identification of clonal amplifications of these cells in autoimmune and infectious diseases, transplantation recipients, paroxysmal nocturnal hemoglobinuria (PNH), and cancer. The assay for mutations of the X-chromosomal hypoxanthine </span>guanine phosphoribosyltransferase (</span></span></span><em>HPRT</em>) gene has gained popular acceptance for this purpose since viable mutant cells can be recovered for molecular and other analyses. Although the major application of the <em>HPRT</em><span> T cell assay remains human population monitoring, the enrichment of activated T cells in the mutant fraction in individuals with ongoing immunological processes has demonstrated the utility of surrogate selection, a method that uses somatic mutation as a surrogate marker for the in vivo T cell proliferation that underlies immunological processes to investigate clinical disorders with immunological features. Studies encompassing a wide range of clinical conditions are reviewed. Despite the historical importance of the </span><em>HPRT</em> mutation system in validating surrogate selection, there are now additional mutational and other methods for identifying immunologically active T cells. These methods are reviewed and provide insights for strategies to extend surrogate selection in future studies.</p></div>","PeriodicalId":49789,"journal":{"name":"Mutation Research-Reviews in Mutation Research","volume":"789 ","pages":"Article 108414"},"PeriodicalIF":6.4000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Molecular characterization of hypoxanthine guanine phosphoribosyltransferase mutant T cells in human blood: The concept of surrogate selection for immunologically relevant cells\",\"authors\":\"Noah A. Kaitz ,&nbsp;Cindy L. Zuleger ,&nbsp;Peng Yu ,&nbsp;Michael A. Newton ,&nbsp;Richard J. Albertini ,&nbsp;Mark R. Albertini\",\"doi\":\"10.1016/j.mrrev.2022.108414\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span><span>Somatic cell </span>gene mutations<span><span><span> arise in vivo due to replication errors during DNA synthesis<span> occurring spontaneously during normal DNA synthesis or as a result of replication on a DNA template damaged by endogenous or exogenous </span></span>mutagens<span>. In principle, changes in the frequencies of mutant cells in vivo in humans reflect changes in exposures to exogenous or endogenous DNA damaging insults, other factors being equal. It is becoming increasingly evident however, that </span></span>somatic mutations<span><span> in humans have a far greater range of interpretations. For example, mutations in lymphocytes provide invaluable probes for in vivo cellular and molecular processes, providing identification of clonal amplifications of these cells in autoimmune and infectious diseases, transplantation recipients, paroxysmal nocturnal hemoglobinuria (PNH), and cancer. The assay for mutations of the X-chromosomal hypoxanthine </span>guanine phosphoribosyltransferase (</span></span></span><em>HPRT</em>) gene has gained popular acceptance for this purpose since viable mutant cells can be recovered for molecular and other analyses. Although the major application of the <em>HPRT</em><span> T cell assay remains human population monitoring, the enrichment of activated T cells in the mutant fraction in individuals with ongoing immunological processes has demonstrated the utility of surrogate selection, a method that uses somatic mutation as a surrogate marker for the in vivo T cell proliferation that underlies immunological processes to investigate clinical disorders with immunological features. Studies encompassing a wide range of clinical conditions are reviewed. Despite the historical importance of the </span><em>HPRT</em> mutation system in validating surrogate selection, there are now additional mutational and other methods for identifying immunologically active T cells. These methods are reviewed and provide insights for strategies to extend surrogate selection in future studies.</p></div>\",\"PeriodicalId\":49789,\"journal\":{\"name\":\"Mutation Research-Reviews in Mutation Research\",\"volume\":\"789 \",\"pages\":\"Article 108414\"},\"PeriodicalIF\":6.4000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Mutation Research-Reviews in Mutation Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1383574222000047\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mutation Research-Reviews in Mutation Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1383574222000047","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 1

摘要

体细胞基因突变是由于正常DNA合成过程中自发发生的DNA合成过程中的复制错误或由于内源性或外源性诱变剂损伤的DNA模板上的复制而在体内产生的。原则上,在其他因素相同的情况下,人体体内突变细胞频率的变化反映了外源性或内源性DNA损伤损伤暴露的变化。然而,越来越明显的是,人类体细胞突变的解释范围要大得多。例如,淋巴细胞的突变为体内细胞和分子过程提供了宝贵的探针,为自身免疫性疾病和感染性疾病、移植受体、阵发性夜间血红蛋白尿(PNH)和癌症中这些细胞的克隆扩增提供了鉴定。对x染色体次黄嘌呤鸟嘌呤磷酸核糖基转移酶(HPRT)基因突变的测定已经获得了广泛的接受,因为可以恢复活的突变细胞进行分子和其他分析。尽管HPRT T细胞检测的主要应用仍然是人群监测,但在正在进行免疫过程的个体中,突变部分中活化T细胞的富集已经证明了替代选择的效用,这种方法使用体细胞突变作为体内T细胞增殖的替代标记,这是免疫过程的基础,用于研究具有免疫特征的临床疾病。研究包括广泛的临床条件进行审查。尽管HPRT突变系统在验证替代选择方面具有重要的历史意义,但现在有更多的突变和其他方法来识别免疫活性T细胞。对这些方法进行了综述,并为今后研究中扩展替代选择的策略提供了见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Molecular characterization of hypoxanthine guanine phosphoribosyltransferase mutant T cells in human blood: The concept of surrogate selection for immunologically relevant cells

Molecular characterization of hypoxanthine guanine phosphoribosyltransferase mutant T cells in human blood: The concept of surrogate selection for immunologically relevant cells

Molecular characterization of hypoxanthine guanine phosphoribosyltransferase mutant T cells in human blood: The concept of surrogate selection for immunologically relevant cells

Molecular characterization of hypoxanthine guanine phosphoribosyltransferase mutant T cells in human blood: The concept of surrogate selection for immunologically relevant cells

Somatic cell gene mutations arise in vivo due to replication errors during DNA synthesis occurring spontaneously during normal DNA synthesis or as a result of replication on a DNA template damaged by endogenous or exogenous mutagens. In principle, changes in the frequencies of mutant cells in vivo in humans reflect changes in exposures to exogenous or endogenous DNA damaging insults, other factors being equal. It is becoming increasingly evident however, that somatic mutations in humans have a far greater range of interpretations. For example, mutations in lymphocytes provide invaluable probes for in vivo cellular and molecular processes, providing identification of clonal amplifications of these cells in autoimmune and infectious diseases, transplantation recipients, paroxysmal nocturnal hemoglobinuria (PNH), and cancer. The assay for mutations of the X-chromosomal hypoxanthine guanine phosphoribosyltransferase (HPRT) gene has gained popular acceptance for this purpose since viable mutant cells can be recovered for molecular and other analyses. Although the major application of the HPRT T cell assay remains human population monitoring, the enrichment of activated T cells in the mutant fraction in individuals with ongoing immunological processes has demonstrated the utility of surrogate selection, a method that uses somatic mutation as a surrogate marker for the in vivo T cell proliferation that underlies immunological processes to investigate clinical disorders with immunological features. Studies encompassing a wide range of clinical conditions are reviewed. Despite the historical importance of the HPRT mutation system in validating surrogate selection, there are now additional mutational and other methods for identifying immunologically active T cells. These methods are reviewed and provide insights for strategies to extend surrogate selection in future studies.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
12.20
自引率
1.90%
发文量
22
审稿时长
15.7 weeks
期刊介绍: The subject areas of Reviews in Mutation Research encompass the entire spectrum of the science of mutation research and its applications, with particular emphasis on the relationship between mutation and disease. Thus this section will cover advances in human genome research (including evolving technologies for mutation detection and functional genomics) with applications in clinical genetics, gene therapy and health risk assessment for environmental agents of concern.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信